BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 22976378)

  • 21. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
    Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
    Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
    Bruin SC; de Ronde JJ; Wiering B; Braaf LM; de Wilt JH; Vincent AD; van Velthuysen ML; Ruers TJ; Wessels LF; van't Veer LJ
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S560-9. PubMed ID: 23783809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery.
    Hu Y; Gaedcke J; Emons G; Beissbarth T; Grade M; Jo P; Yeager M; Chanock SJ; Wolff H; Camps J; Ghadimi BM; Ried T
    Genes Chromosomes Cancer; 2018 Mar; 57(3):140-149. PubMed ID: 29119627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk for CRC in diabetic patients with the nonrisk allele of SNPs at 8q24.
    Ishimaru S; Mimori K; Yamamoto K; Inoue H; Imoto S; Kawano S; Yamaguchi R; Sato T; Toh H; Iinuma H; Maeda T; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Sugihara K; Hase K; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Barnard GF; Miyano S; Mori M
    Ann Surg Oncol; 2012 Sep; 19(9):2853-8. PubMed ID: 22434246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
    Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
    Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer.
    Killian A; Di Fiore F; Le Pessot F; Blanchard F; Lamy A; Raux G; Flaman JM; Paillot B; Michel P; Sabourin JC; Tuech JJ; Michot F; Kerckaert JP; Sesboüé R; Frebourg T
    Gastroenterology; 2007 Feb; 132(2):645-53. PubMed ID: 17258723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No evidence that associations of incident, sporadic colorectal adenoma with its major modifiable risk factors differ by chromosome 8q24 region rs6983267 genotype.
    Yang B; Thyagarajan B; Gross MD; Fedirko V; Goodman M; Bostick RM
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E193-200. PubMed ID: 24115145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.
    Daraei A; Salehi R; Salehi M; Emami MH; Janghorbani M; Mohamadhashem F; Tavakoli H
    Med Oncol; 2012 Jun; 29(2):1044-9. PubMed ID: 21567271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
    Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
    Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
    De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
    Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267.
    Gong J; Tian J; Lou J; Wang X; Ke J; Li J; Yang Y; Gong Y; Zhu Y; Zou D; Peng X; Yang N; Mei S; Zhong R; Chang J; Miao X
    Ann Oncol; 2018 Mar; 29(3):632-639. PubMed ID: 29267898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients.
    Hayama T; Iinuma H; Watanabe T
    Oncol Rep; 2007 Oct; 18(4):779-84. PubMed ID: 17786336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.